SahinerUM, CivelekE, TuncerA, et al.Chronic urticaria: Etiology and natural course in children. Int Arch Allergy Immunol, 2011; 156:224–230.
2.
ZuberbierT, AbererW, AseroR, et al.The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria: The 2013 revision ad update. Allergy, 2014; 69:868–887.
3.
Olszowiec-ChlebnaM, SztafinskaA, StelmachI. Teenager suffered from idiopathic anaphylaxis and chronic spontaneous urticaria successfully treated with omalizumab–A case report. Pediatr Allergy Immunol Pneumol, 2016; [Epub ahead of print]; DOI: 10.1089/ped.2015.0580.
4.
KapkanA, FerrerM, BernsteinJA, et al.Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol, 2016; 137:474–481.
5.
WahnU. Anti-IgE for chronic urticaria – Are children little adults after all?. Pediatr Allergy Immunol, 2015; 26:488–489.
6.
ChippsBE, FigliomeniM, SpectorS. Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma. Allergy Asthma Proc, 2012; 33:377–385.
7.
ViswanathanRV, MossMH, MathurSK. Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria. Allergy Asthma Proc, 2013; 34:446–452.
